Cytoprotective Agent class drugs

1 result

Dexrazoxane (dexrazoxane hydrochloride)

(Dexrazoxane Hydrochloride)
Breckenridge Pharmaceutical, Inc.
Usage: Dexrazoxane for Injection is indicated to reduce cardiomyopathy risk in women with metastatic breast cancer who have received 300 mg/m² of doxorubicin and are continuing treatment. It is not to be used at the start of doxorubicin therapy.